Intervention
Furosemide
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 47 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
47 shownContrast-Induced Acute Kidney Injury Prevention in Acute Heart FailureNCT07550790 · 2026-07-01
RECRUITINGDiuretics vs. Afterload Reduction for Treatment of HeartLogic AlertsNCT06218199 · 2021-07-08
RECRUITINGACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.NCT07737964 · 2026-10-01
NOT_YET_RECRUITINGFurosemide vs Placebo in Severe Preeclampsia PostpartumNCT07648251 · 2026-06-15
NOT_YET_RECRUITINGSURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart FailureNCT07631780 · 2026-06-01
NOT_YET_RECRUITINGA Study of Ultra High Dose Diuretics to Treat Heart FailureNCT06036914 · 2023-11-27
COMPLETEDDiuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic ResistanceNCT05986773 · 2023-10-10
TERMINATEDA Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver CirrhosisNCT05741372 · 2023-09-07
COMPLETEDComparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate CancerNCT05779943 · 2023-04-27
ACTIVE_NOT_RECRUITINGThe Addition of Inhaled Furosemide to Standard Treatment of COPD ExacerbationNCT05769738 · 2023-03-01
UNKNOWNLasix for the Prevention of De Novo Postpartum HypertensionNCT04752475 · 2021-10-20
COMPLETEDA Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986308 in Healthy ParticipantsNCT04763226 · 2021-04-14
COMPLETEDEfficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAHNCT05569655 · 2021-04-06
UNKNOWNTorsemide Comparison With Furosemide for Management of Patients With Stable Heart FailureNCT05093621 · 2021-02-08
COMPLETEDFurosemide vs. Placebo for Severe Antepartum HypertensionNCT04615624 · 2021-01-04
COMPLETEDA Trial to Study BAY1753011 in Patients With Congestive Heart FailureNCT03901729 · 2019-05-29
COMPLETEDProtocol of Diuretics Use in Congestive Therapy in Heart FailureNCT03892148 · 2019-05-17
COMPLETEDAn Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop DiureticNCT03730961 · 2019-01-17
COMPLETEDTRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart FailureNCT03296813 · 2018-07-11
COMPLETEDPharmacokinetics, Safety and Tolerability of Concurrent Doses of BIA 5-1058 and FurosemideNCT07173738 · 2018-06-11
COMPLETEDIntravenous Vasodilator vs. Inotropic Therapy in Patients With Heart FailureNCT02767024 · 2018-05-01
WITHDRAWNEffects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)NCT04628325 · 2017-03-01
COMPLETEDA Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy SubjectsNCT03010475 · 2017-01-05
COMPLETEDShort-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in ADHFNCT02649998 · 2017-01-01
WITHDRAWNSubcutaneous Furosemide in Acute Decompensated Heart Failure PilotNCT02877095 · 2016-12-19
COMPLETEDPrevention of Severe Postpartum HypertensionNCT02450773 · 2015-08-01
WITHDRAWNEffect of Furosemide Withdraw in Stable Chronic Heart Failure OutpatientsNCT02689180 · 2015-05-01
UNKNOWNAquaresis Utility for Hyponatremic Acute Heart Failure StudyNCT02183792 · 2014-12-01
COMPLETEDAerosol Inhalation Treatment for Dyspnea - PatientsNCT02524054 · 2014-11-01
COMPLETEDA Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011)NCT01558674 · 2014-05-23
TERMINATEDCombination Diuretic Therapy for Acute Decompensated Heart FailureNCT05840536 · 2014-05-01
WITHDRAWNA Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II)NCT02047422 · 2014-01-01
WITHDRAWNThe Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart FailureNCT01942109 · 2013-09-01
UNKNOWNDiuretics and Dopamine in Heart Failure With Preserved Ejection FractionNCT01901809 · 2013-08-01
COMPLETEDEffectiveness of a Diuretic Algorithm in Clinical Stability in Heart Failure PatientsNCT02068937 · 2013-05-01
COMPLETEDUltrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid OverloadNCT01508260 · 2013-03-01
WITHDRAWNOUTpatient Intravenous LASix Trial in Reducing Hospitalization for Acute Decompensated Heart FailureNCT04691687 · 2012-05-01
COMPLETEDTroponin I Release After High Diuretic DosesNCT01419132 · 2011-08-01
COMPLETEDBumetanide Versus Furosemide in Heart FailureNCT00372762 · 2011-01-01
WITHDRAWNEffect of Furosemide on Obesity-induced Glomerular HyperfiltrationNCT00962286 · 2009-09-01
TERMINATEDThe Effects of Decreasing the Lasix Dose on the Cardiorenal SystemNCT00982423 · 2009-07-01
COMPLETEDComparing the Effects of Conivaptan and Diuretics on Plasma Neurohormones and Renal Blood Flow in Patients With Chronic Congestive Heart FailureNCT00924014 · 2009-07-01
UNKNOWNDopamine in Acute Decompensated Heart Failure (DAD-HF) TrialNCT00937092 · 2009-01-01
UNKNOWNA Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or HydrochlorothiazideNCT00671424 · 2008-03-01
COMPLETEDEffect of a New Formulation of Torasemide (Prolonged Release)on Myocardial Fibrosis in Patients With Heart Failure.NCT00409942 · 2007-03-01
COMPLETEDLoop Diuretics in Chronic Kidney DiseaseNCT00478543 · 2005-09-01
COMPLETEDHypertension Screening and Treatment ProgramNCT00007592 · 1989-06-01
COMPLETEDCommon conditions
Heart Failure14Acute Heart Failure5Congestive Heart Failure3Hypertension3Heart Decompensation2Hypertension, Pregnancy-Induced2Pulmonary Arterial Hypertension2Acute Decompensated Heart Failure1ADHF1Cardiac Failure1Chronic Heart Failure1Chronic Kidney Disease1Chronic Obstructive Pulmonary Disease Exacerbation1Congestion1COPD Exacerbation1Diabetes1Diabetes Mellitus, Type 21Diuretic Resistance1Dyspnea1Healthy1Healthy Participants1Heart Failure (HF)1Heart Failure Acute1Heart Failure, Congestive1Heart Failure, Diastolic1
Leading sponsors
Bristol-Myers Squibb
2
Hospital de Clinicas de Porto Alegre
2
Mayo Clinic
2
University of Palermo
2
Adrian Hernandez
1
American University of Beirut Medical Center
1
Bayer
1
Beth Israel Deaconess Medical Center
1
Bial - Portela C S.A.
1
Boehringer Ingelheim
1
Chinese Pulmonary Vascular Disease Research Group
1
Chinese University of Hong Kong
1
Columbia University
1
Duke University
1
Emory University
1
Trial status mix
COMPLETED25
WITHDRAWN7
UNKNOWN6
NOT_YET_RECRUITING3
TERMINATED3
RECRUITING2
ACTIVE_NOT_RECRUITING1
Phase mix
PHASE413
NA10
PHASE39
PHASE18
PHASE28
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.